CBD shows promise for Autism-Related anxiety in new trial
NCT ID NCT05015439
First seen Nov 11, 2025 · Last updated May 12, 2026 · Updated 20 times
Summary
This study tests whether cannabidiol (CBD) can reduce anxiety, mood problems, and agitation in adults with autism spectrum disorder. Forty participants will receive CBD for six weeks and a placebo for six weeks, with a two-week break in between. Researchers will measure changes in behavior, anxiety, and daily functioning using standard questionnaires.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
JHBMC
RECRUITINGBaltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.